A Reading on chronic interstitial lung disease

In Partial Fulfillment of the Requirements

RT-124 in Clinical Education 1
Adult ICU

Submitted to:
Lyod Deocades, RTRP
Clinical Instructor

Submitted by:
CYRIL G. SOLIMAN
Group 2

Date Submitted:
October 9, 2021
Title: Progression of fibrosing interstitial lung disease

Bibliography:
Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in
idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183(4):431–40.
Summary:
Interstitial lung disease (ILD) is a heterogeneous group of diseases
characterized by inflammation and fibrosis of the lung parenchyma.
Idiopathic pulmonary fibrosis (IPF) is the most common, severe, and
progressive subtype of ILD. Other ILD subtypes also have a progressive
fibrosing phenotype.IPF is primarily a fibrotic ILD, while fibrosis in non-IPF
ILDs is often preceded or associated with inflammation. Despite important
differences, distinct ILD subtypes often have overlapping morphological
features and common pathological mechanisms. We discuss the clinical
utility of ILD classification according to disease behavior and potential
definitions of progressive fibrosing ILD.

Reaction:
I agree in the article its gives as information and knowledge about intertial lung
diseases. Patients with PF-ILD typically have self-perpetuating fibrosis
characterized by worsening lung function, dyspnea, physical performance, and
quality of life, as well as a poor response to therapy and early mortality.
Approximately 20–30% of patients with ILD are estimated to have this condition.